GlassScriptPhysician profile
Caroline Miranda
NPI 1255741732
$1,403.60
in general payments reported to CMS, 2019-2025
18 companies · $370 in 2025
The $370 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $13.56 · 2021: $48.48 · 2022: $481 · 2023: $101 · 2024: $136 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $606.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $307.00 | 2022 | |
| Abbvie INC. | $238.10 | 2022-2025 | |
| Eisai INC. | $138.70 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $133.79 | 2021-2024 | Austedo Xr |
| Akcea Therapeutics, INC. | $104.72 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $70.97 | 2024 | Hyqvia |
| Lundbeck LLC | $61.07 | 2019 | |
| Emd Serono, INC. | $57.57 | 2023 | Mavenclad |
| Astrazeneca Pharmaceuticals LP | $47.81 | 2025 | Wainua |
| Alexion Pharmaceuticals, INC. | $44.56 | 2019 | |
| Upsher-Smith Laboratories LLC | $31.70 | 2020-2023 | |
| Ultragenyx Pharmaceutical INC. | $30.00 | 2022 | |
| Pfizer INC. | $26.70 | 2024 | |
| Catalyst Pharmaceuticals, INC. | $25.00 | 2023 | Firdapse |
| Csl Behring | $24.16 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $23.70 | 2024 | Gamunex-C |
| Acorda Therapeutics, INC | $19.05 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $19.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Miranda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.